Viewing nowRosuvam 5mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
McNulty Pharmaceutical Co., Ltd.

MFDS item code 202005250 · Approved 2020.07.21 · Insurance code 641502670
Treatment of dyslipidemia, reduction of cardiovascular disease risk, and inhibition of atherosclerosis progression
This medication helps patients with primary hypercholesterolemia and mixed dyslipidemia when dietary changes and exercise are insufficient. It is also used as an adjunct to diet or other lipid-lowering therapy in patients with homozygous familial hypercholesterolemia. It lowers total cholesterol and LDL-cholesterol levels in patients with hypercholesterolemia and helps delay the progression of atherosclerosis. For children aged 10 to 17 with heterozygous familial hypercholesterolemia, it helps reduce cholesterol levels. It is also used adjunctively in patients with primary dysbetalipoproteinemia and contributes to reducing the risk of stroke, myocardial infarction, and arterial revascularization in elderly patients at high cardiovascular risk. Overall, this drug is used to effectively improve cholesterol levels and reduce cardiovascular disease risk.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), combined hyperlipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug and continue it throughout the treatment period. This drug may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted as a maintenance dose. The maintenance dose is 10 milligrams once daily, and most patients are controlled at this dose. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer, according to LDL cholesterol levels, treatment goals, and the patient's response; the dose may be increased to a maximum of 20 milligrams daily. 3. Older adults: No dose adjustment is required. 4. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering this drug at 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment: Systemic exposure to rosuvastatin was not increased in patients with a Child-Pugh score of 7 or less, but was increased in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this drug to patients with active liver disease. 6. Race: As systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Age 10 years to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.
This drug should not be used in certain patients. For example, individuals allergic to this medication, those with severe liver impairment, or those with muscle-related diseases should avoid it. Additionally, special caution is required for pregnant or breastfeeding women and women of childbearing age who are not using appropriate contraception; it should only be used if there is assurance of low pregnancy probability. Care should be taken when prescribing high doses to patients with a history of muscle disease or moderate to severe renal impairment due to the risk of muscle damage. Patients with genetic disorders that prevent lactose digestion should also avoid this medication. Patients with liver dysfunction or those consuming excessive alcohol should undergo regular liver enzyme tests and use the medication cautiously. If muscle pain or weakness occurs, patients should inform their doctor immediately, and in severe cases, they may need to stop the medication. Special monitoring is necessary prior to and after treatment in elderly patients, those with reduced kidney function, or those with hypothyroidism who have risk factors for muscle damage. The use of this drug should be temporarily suspended when acute severe illness occurs. This medication can rarely induce severe muscle weakness or ocular muscle weakness; if such symptoms appear, it should be stopped immediately. When used with certain other medications, the risk of muscle damage may increase; therefore, consult with a doctor about any concomitant medications. High-dose administration may result in transient kidney proteinuria, so it is advisable to undergo regular kidney function tests. Asian patients may exhibit higher drug concentrations, thus requiring dose adjustments. Pediatric and adolescent patients should be considered for their effects on growth and development. This medication has been reported to cause various adverse reactions such as liver dysfunction, increased risk of diabetes, and severe skin reactions; thus, immediate consultation with medical staff is necessary if symptoms arise. This medication should not be used during pregnancy or breastfeeding, and women planning a pregnancy should use appropriate contraceptive methods. There is no specific antidote for overdose, so treatment should be symptomatic and include liver function and muscle enzyme tests. Caution is advised when driving or operating machinery, as dizziness may occur. It is essential to consult with a doctor and undergo regular check-ups to ensure the safe use of this medication.
Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ophthalmoplegia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), drug-induced morbilliform rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal hepatic failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, numbness, dysesthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air and moisture from entering, and it is best stored at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication and prevent deterioration.
Yellow round film-coated tablets
30 tablets (15 tablets/PTP x 2 packs)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 5.2mg
Tablet · Prescription medication
McNulty Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.